Welcome to the 5th mRNA Process Development & CMC Summit
CMC bottlenecks are deciding which mRNA therapeutics make it into clinical trials, who gets to market first, and who gets left behind. The window to shape that outcome is now, not next year.
Enter the 5th mRNA Process Development & CMC Summit. This is where biopharma's C-level decision-makers meet the CDMOs, manufacturers, and sequencers actively working on, and solving these problems
Designed for mRNA & CMC experts, our 5th iteration is tackling the industry’s two biggest challenges: advancing the next frontier of mRNA-enabled cell & gene therapies and accelerating the development of scalable, next-generation mRNA therapeutics. When it comes to cell and gene therapy, if you’re not leading the pack, you’re falling behind.
Over 3 days, 120+ global experts will bring the data and strategies that will write the industry playbook on improving consistency, scalability and delivery while meeting regulatory expectations.
This meeting will define the trajectory of the next 12 months – make sure you’re in the room.
I'm excited to join this summit to exchange practical insights on mRNA process development and to learn new approaches and materials that improve mRNA quality for therapeutics
Jack (Chia Chieh) Chu, Principal Scientist, GSK
I look forward to connecting with scientists and industry leaders working to bring safe and effective mRNA medicines to the clinic
Amit Khandhar, Director, Formulations, HDT Bio
I’m very interested in how the industry will advance the capabilities of circular RNA and overcome LNP CMC hurdles (especially with active binders)
Zimeng Wang, Associate Principal Scientist, AstraZeneca
To network with other mRNA colleagues and hear their perspective on the constantly evolving mRNA field and learn the developments in the analytical and CMC strategy in how to approach the hurdles we face Shirisha Meda, Associate Director, BioNTech
It is important to discuss how R&D, process development, CMC and manufacturing groups can work together to ensure robust therapeutic development.
T.J. Cradick, Chief Scientific Officer, HuidaGene Therapeutics
Explore the Full Event Guide
- Gain exclusive insight into the latest advances across mRNA, gene editing, self-amplifying RNA, and next-generation RNA modalities
- Learn how leading biopharma organizations are overcoming the industry's most pressing manufacturing, delivery, and analytical challenges
- Explore real-world case studies showcasing successful strategies for scalability, purification, process development, and regulatory readiness
- Identify the sessions, speakers, and networking opportunities most relevant to your CMC, analytical development, and process development objectives
World-Class Speaker Faculty Includes:
Official Partners
Previously Attending Companies Include:
Explore Related Events
Explore the Agenda
Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.